Breo Ellipta
PHONETIC PRONUNCIATION: Breo Ellipta
Description
Breo Ellipta: A Comprehensive Guide to Its Uses, Dosage, Demographic, Side Effects, Interactions, and Generic Options Breo Ellipta is a prescription drug for adults who have chronic obstructive pulmonary disease (COPD), including chronic bronchitis or emphysema. This medication contains a combination of two active ingredients, fluticasone furoate, and vilanterol. Fluticasone furoate is a corticosteroid that reduces inflammation in the lungs, while vilanterol is a long-acting beta-agonist that relaxes the airways. The drug is available in the form of an inhalation powder that is used once a day. Uses of Breo Ellipta Breo Ellipta is used for the management of COPD in adults. It helps to improve lung function and quality of life by reducing inflammation in the lungs and relaxing the airways. The drug is also used to prevent acute exacerbations or worsening of symptoms in people with COPD. Dosage and Administration The recommended dose of Breo Ellipta for adults is one inhalation once a day. The inhaler should be used at the same time each day, and the dose should not be exceeded. The drug should only be used as directed, and if symptoms persist or worsen, it is important to consult a healthcare provider. Demographic Breo Ellipta is approved for use in adults aged 18 years and above who have COPD. It is not recommended for use in children. Side Effects As with any medication, Breo Ellipta may cause side effects in some people. The most common side effects of the drug include headache, sore throat, cough, and nausea. Other possible side effects include: - Thrush or yeast infection in the mouth or throat - Pneumonia - Bone loss - Growth retardation in children and adolescents - Glaucoma - Cataracts Interactions Breo Ellipta may interact with other medications, including: - Beta-blockers - Diuretics - Antidepressants - Antipsychotics - HIV protease inhibitors It is important to inform the healthcare provider of all medications being taken before starting treatment with Breo Ellipta. Generic Options Breo Ellipta is a brand-name medication and does not have a generic version currently available. However, there are other medications that contain similar active ingredients, such as Advair Diskus and Symbicort. Conclusion Breo Ellipta is an effective medication for the management of COPD in adults. Its combination of two active ingredients, fluticasone furoate, and vilanterol, helps to reduce inflammation in the lungs and relax the airways, improving lung function and quality of life. Like any medication, Breo Ellipta may cause side effects and may interact with other medications. It is important to consult a healthcare provider to discuss the benefits and risks of using Breo Ellipta.
Faq for Breo Ellipta
Breo Ellipta contains a combination of fluticasone furoate and vilanterol. Fluticasone furoate is a corticosteroid that helps reduce inflammation in the airways, while vilanterol is a long-acting bronchodilator that relaxes the muscles in the airways, making it easier to breathe.
Breo Ellipta is primarily used to treat chronic obstructive pulmonary disease (COPD) and asthma in adults. It is not for use in acute asthma or for the relief of sudden, severe symptoms.
The recommended dosage for Breo Ellipta is one inhalation once daily. It is important to use it exactly as prescribed by your healthcare provider.
Yes, Breo Ellipta is approved for use in both asthma and COPD. However, it is essential to consult your doctor for specific guidance on your condition and treatment.
Common side effects of Breo Ellipta may include headache, throat irritation, upper respiratory tract infection, and cough. However, everyone's response to medication can vary, so it is important to talk to your healthcare provider about any concerning symptoms.
It is crucial to inform your healthcare provider about all the medications you are currently taking, including over-the-counter drugs and supplements. Certain medications may interact with Breo Ellipta, so it is important to discuss this with your doctor to avoid any potential complications.
Breo Ellipta begins working immediately, but it may take several days to weeks to experience the full benefits of the medication. It is important to continue using it regularly as prescribed for optimal results.
Breo Ellipta is not approved for use in children younger than 18 years old. It is a medication primarily indicated for adults with asthma and COPD.
No, it is essential to continue using Breo Ellipta as prescribed by your healthcare provider, even if your symptoms improve. Suddenly stopping the medication can lead to worsening of symptoms. Always consult your doctor before making any changes to your treatment plan.
Yes, Breo Ellipta is a prescription medication that can be obtained only with a valid prescription from a healthcare provider.